FDA Warns Weight-Loss Supplement Manufacturers Against Sale of BMPEA
On April 23, 2015, the Food and Drug Administration (“FDA”) issued warning letters to companies selling weight loss/performance supplements containing BMPEA (beta-methylphenethylamine). Manufacturers have made representations that BMPEA is an extract of the botanical Acacia rigidula however, there is no evidence supporting this claim. The FDA warned manufacturers that BMPEA is not a “dietary ingredient” as defined by the Federal Food, Drug, and Cosmetic Act, which means that any products identifying BMPEA as a dietary supplement are treated as being “misbranded,” which is a violation of federal law. BMPEA is believed to be a synthetic stimulant with dangerous properties similar to amphetamine, which can lead to serious injury or death.
The FDA warning was issued to the following companies:
|Hi-Tech Pharmaceuticals, Inc.||Faxtin-XR (extended release)
Fastin-RR (rapid release)
Lipodrene (Ephedra free)
|Tribravus Enterprises, LLC d/b/a iForce Nutrition||Conquer (Fruit Punch Slam & Raspberry Lemonade)|
|Train Naked Labs, LLC||Critical FX
|Better Body Sports, LLC||Phoenix Extreme|
|Human Evolution Supplements, Inc.||Core Burner|
According to FDA’s website, “[t]hese companies have 15 business days from the date of receipt of the letter to communicate to the agency the specific steps they will take to bring their products into compliance with the law.”
BMPEA is also known as:
- R-beta-methylphenethylamine HCl
- 2- phenyl-1-propanamine
If you or a loved one suffered injuries that you believe were caused by a dietary supplement containing beta-methylphenylethylamine (BMPEA), contact one of the experienced dangerous drug attorneys at Burg Simpson today. Our award-winning lawyers would be happy to discuss your potential claim. Call 1-800-713-9340 or fill out our contact form for a FREE no-obligation consultation today.